PTPI (OTC)
PETROS PHARM INC
$0.008200
+0.001100 (+15.49%)
Prev close: $0.007100
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shulman John David
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.17M
- Employees
- 24
- P/E (TTM)
- —
- P/B (TTM)
- 0.42
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2024 (Q3)
|
$-13.25 | $-7.40 | -5.8550 | -79.18% |
|
Jun 2024 (Q2)
|
$-9.25 | $-19.64 | +10.3850 | +52.89% |
|
Mar 2024 (Q1)
|
$-42.25 | $-36.72 | -5.5300 | -15.06% |
|
Dec 2023 (Q4)
|
$-57.25 | $-28.31 | -28.9450 | -102.26% |
Financial Statements
| Revenues | $4.97M |
| Benefits Costs and Expenses | $23.30M |
| Costs And Expenses | $23.30M |
| Operating Expenses | $21.78M |
| Selling, General, and Administrative Expenses | $8.95M |
| Operating Income/Loss | -$17.88M |
| Income/Loss From Continuing Operations After Tax | -$18.33M |
| Income/Loss From Continuing Operations Before Tax | -$18.33M |
| Interest Income/Expense After Provision For Losses | $228.39K |
| Interest Income/Expense Operating, Net | $228.39K |
| Net Income/Loss | -$7.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.02M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.54M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $12.48M |
| Preferred Stock Dividends And Other Adjustments | $12.48M |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | $64.64 |
| Diluted Earnings Per Share | $64.64 |
| Basic Average Shares | 31,006,321 |
| Diluted Average Shares | 31,006,321 |
| Assets | $6.13M |
| Current Assets | $6.13M |
| Noncurrent Assets | $0.00 |
| Liabilities | $2.77M |
| Current Liabilities | $2.77M |
| Accounts Payable | $421.14K |
| Other Current Liabilities | $2.34M |
| Noncurrent Liabilities | $0.00 |
| Equity | $3.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.37M |
| Temporary Equity | $1.00K |
| Liabilities And Equity | $6.13M |
| Net Cash Flow From Operating Activities | -$4.84M |
| Net Cash Flow From Operating Activities, Continuing | -$2.75M |
| Net Cash Flow From Investing Activities | -$2.37M |
| Net Cash Flow From Investing Activities, Continuing | -$4.36M |
| Net Cash Flow From Financing Activities | $7.02M |
| Net Cash Flow From Financing Activities, Continuing | $6.25M |
| Net Cash Flow | -$184.71K |
| Net Cash Flow, Continuing | -$854.52K |
| Comprehensive Income/Loss | -$7.02M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.02M |
| Other Comprehensive Income/Loss | $0.00 |